פיברוגאמין 1250IU FXIII

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

FACTOR XIII

MAH:

CSL BEHRING LTD., ISRAEL

ATC_code:

B02BD07

pharmaceutical_form:

POWDER FOR SOLUTION FOR INJECTION

composition:

FACTOR XIII 1250 IU

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

CSL BEHRING GmbH, GERMANY

therapeutic_group:

COAGULATION FACTOR XIII

therapeutic_area:

COAGULATION FACTOR XIII

therapeutic_indication:

Congenital or acquired Factor XIII deficiency or to promote healing of wounds and bone fractures. Congenital deficiency of Factor XIII and resultant haemorrhagic syndroms

authorization_date:

2023-05-31